Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 4
Submit an article Journal homepage
2,925
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Shikonin combined with methotrexate regulate macrophage polarization to treat psoriasis

Tingjun Taoa Department of Dermatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China;b The First Clinical Academy, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China;c Department of Dermatology, Yangjiang People’s Hospital, Yangjiang, Guangdong, ChinaView further author information
,
Yan Chena Department of Dermatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China;b The First Clinical Academy, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China;c Department of Dermatology, Yangjiang People’s Hospital, Yangjiang, Guangdong, China;d Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, Anhui, ChinaView further author information
,
Bochen Laie The Second Clinical Academy, Xinjiang Medical University, Xinshi District, Urumqi, Xinjiang Uygur Autonomous Region, ChinaView further author information
,
Jinhua Wanga Department of Dermatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China;b The First Clinical Academy, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, ChinaView further author information
,
Weiliang Wangc Department of Dermatology, Yangjiang People’s Hospital, Yangjiang, Guangdong, ChinaView further author information
,
Weimian Xiaof Department of Dermatology, Qingyuan Skin Disease Hospital, Qingyuan, Guangdong, ChinaView further author information
&
Xushan Chaa Department of Dermatology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 11146-11155 | Received 09 Feb 2022, Accepted 26 Mar 2022, Published online: 29 Apr 2022

References

  • Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. Jama. 2020;323:1945–1960. Epub 2020/ 05/20.
  • Kamiya K, Kishimoto M, Sugai J, et al. Risk factors for the development of psoriasis. Int J Mol Sci. 2019;20:4347. Epub 2019/ 09/08.
  • Funes SC, Rios M, Escobar-Vera J, et al. Implications of macrophage polarization in autoimmunity. Immunology. 2018;154:186–195.
  • Zhang J, Lin Y, Li C, et al. IL-35 decelerates the inflammatory process by regulating inflammatory cytokine secretion and M1/M2 macrophage ratio in psoriasis. J Immunol. 2016;197:2131–2144. Epub 2016/ 08/17.
  • Li L, Zhang HY, Zhong XQ, et al. PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization. Life Sci. 2020;243:117231. Epub 2019/ 12/31.
  • Zhang CS, Yu JJ, Parker S, et al. Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: a systematic review. Int J Dermatol. 2014;53:1305–1318. Epub 2014/ 09/12.
  • Guo C, He J, Song X, et al. Pharmacological properties and derivatives of shikonin-A review in recent years. Pharmacol Res. 2019;149:104463. Epub 2019/ 09/26.
  • Boulos JC, Rahama M, Hegazy MF, et al. Shikonin derivatives for cancer prevention and therapy. Cancer Lett. 2019;459:248–267. Epub 2019/ 05/28.
  • Wang J, Zhang Y, Li C, et al. Inhibitory function of Shikonin on MRGPRX2-mediated pseudo-allergic reactions induced by the secretagogue. Phytomedicine. 2020;68:153149. Epub 2020/ 02/08.
  • Yoshida LS, Kawada T, Irie K, et al. Shikonin directly inhibits nitric oxide synthases: possible targets that affect thoracic aorta relaxation response and nitric oxide release from RAW 264.7 macrophages. J Pharmacol Sci. 2010;112:343–351. Epub 2010/ 03/04.
  • Kuang Y, Zhang H, Zhu W, et al. [Effect of methotrexate on regulation for the number of regulatory T cells and expression of Foxp3 in psoriasis]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43:835–842. Epub 2018/ 09/11.
  • Di Cesare A, Di Meglio P, Nestle FO. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009;129:1339–1350. Epub 2009/ 03/27.
  • Yang L, Li B, Dang E, et al. Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3. J Dermatol Sci. 2016;81:85–92. Epub 2015/ 12/03.
  • Miyoshi K, Takaishi M, Nakajima K, et al. Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor. J Invest Dermatol. 2011;131:108–117. Epub 2010/ 09/03.
  • Yang L, Jin L, Ke Y, et al. E3 ligase trim21 ubiquitylates and stabilizes Keratin 17 to induce STAT3 activation in psoriasis. J Invest Dermatol. 2018;138:2568–2577. Epub 2018/ 06/04.
  • Lan X-O, Wang H-X, Qi R-Q, et al. Shikonin inhibits CEBPD downregulation in IL‑17‑treated HaCaT cells and in an imiquimod‑induced psoriasis model. Mol Med Rep. 2020;22:2263–2272. Epub 07/09.
  • Wf EDMUNDSON, Wb GUY. Treatment of psoriasis with folic acid antagonists. AMA Archives Dermatol. 1958;78:200–203.
  • Roenigk HH Jr., HI M, GD W. Use of methotrexate in psoriasis. Arch Dermatol. 1972;105:363–365.
  • Xu Y, Xu X, Gao X, et al. Shikonin suppresses IL-17-induced VEGF expression via blockage of JAK2/STAT3 pathway. Int Immunopharmacol. 2014;19:327–333. Epub 2014/ 02/14.
  • Zhang X, Li J, Yu Y, et al. Shikonin controls the differentiation of CD4+CD25+ regulatory T cells by inhibiting AKT/mTOR pathway. Inflammation. 2019;42:1215–1227.
  • Xie XR, Zhang L, Liu X, et al. [Effect of shikonin on proliferation of keratinocytes induced by interleukin-17 and expression of chemokines]. Zhongguo Zhong Yao Za Zhi. 2015;40:946–949. Epub 2015/ 06/20.
  • Hou Y, Zhu L, Tian H, et al. IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis. Protein Cell. 2018;9:1027–1038. Epub 03/05.
  • Miki H, Han KH. 4-1BBL regulates the polarization of macrophages, and inhibition of 4-1BBL signaling alleviates imiquimod-induced psoriasis. J Immunol. 2020;204:1892–903.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.